Research programme: anti-inflammatories - EndocyteAlternative Names: EC 1669; EC-0565; EC-0746; EC-2319
Latest Information Update: 01 May 2013
At a glance
- Originator Endocyte
- Class Drug conjugates; Small molecules
- Mechanism of Action Folate receptor 1 antagonists; Macrophage inhibitors; MTOR protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Inflammation
- Research Osteoarthritis